Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003, 22: 672-688. 10.1183/09031936.03.00040703.
Article
CAS
PubMed
Google Scholar
Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009, 33: 1165-1185. 10.1183/09031936.00128008.
Article
CAS
PubMed
Google Scholar
Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B: Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 2007, 62: 595-601. 10.1136/thx.2006.064428.
Article
PubMed
PubMed Central
Google Scholar
Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003, 107: 363-369. 10.1161/01.CIR.0000053730.47739.3C.
Article
PubMed
Google Scholar
Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG: C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 250-255.
Article
CAS
PubMed
Google Scholar
Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR: C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006, 61: 23-28.
Article
CAS
PubMed
Google Scholar
de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo De Garcini A, Aguirre-Jaime A, Celli BR, Casanova C: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006, 27: 902-907.
CAS
PubMed
Google Scholar
Antonescu-Turcu AL, Tomic R: C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Curr Opin Pulm Med. 2009, 15: 120-125. 10.1097/MCP.0b013e3283218603.
Article
CAS
PubMed
Google Scholar
Steel DM, Whitehead AS: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994, 15: 81-88. 10.1016/0167-5699(94)90138-4.
Article
CAS
PubMed
Google Scholar
Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999, 340: 448-454. 10.1056/NEJM199902113400607.
Article
CAS
PubMed
Google Scholar
Bozinovski S, Hutchinson A, Thompson M, Macgregor L, Black J, Giannakis E, Karlsson AS, Silvestrini R, Smallwood D, Vlahos R, Irving LB, Anderson GP: Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 177: 269-278.
Article
CAS
PubMed
Google Scholar
Koutsokera A, Kiropoulos TS, Nikoulis DJ, Daniil ZD, Tsolaki V, Tanou K, Papaioannou AI, Germenis A, Gourgoulianis KI, Kostikas K: Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med. 2009, 103: 919-926. 10.1016/j.rmed.2008.12.006.
Article
PubMed
Google Scholar
Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW: Reduced soluble receptor for advanced glycation end products in chronic obstructive pulmonary disease. Eur Respir J. 2011, 37: 516-522. 10.1183/09031936.00029310.
Article
CAS
PubMed
Google Scholar
Dahl M, Vestbo J, Zacho J, Lange P, Tybjærg-Hansen A, Nordestgaard BG: C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax. 2011, 66: 197-204. 10.1136/thx.2009.131193.
Article
PubMed
Google Scholar
Agustí A: Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc. 2007, 4: 522-525. 10.1513/pats.200701-004FM.
Article
PubMed
Google Scholar
Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T: Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med. 2009, 103: 1548-1553. 10.1016/j.rmed.2009.04.005.
Article
PubMed
PubMed Central
Google Scholar
Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol. 1994, 47: 1245-1251. 10.1016/0895-4356(94)90129-5.
Article
CAS
PubMed
Google Scholar
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.
Article
CAS
PubMed
Google Scholar
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH: The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959, 5147: 257-266.
Article
Google Scholar
Brennan P, Silman A: Statistical methods for assessing observer variability in clinical measures. BMJ. 1992, 304: 1491-1494. 10.1136/bmj.304.6840.1491.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310.
Article
CAS
PubMed
Google Scholar
Wu TL, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT: A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal. 2007, 21: 367-371. 10.1002/jcla.20197.
Article
CAS
PubMed
Google Scholar
Liu SF, Wang CC, Chin CH, Chen YC, Lin MC: High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Arch Bronconeumol. 2011, 47: 427-432.
Article
PubMed
Google Scholar
Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP: Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 2006, 440: 1217-1221. 10.1038/nature04672.
Article
CAS
PubMed
Google Scholar
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002, 347: 1557-1565. 10.1056/NEJMoa021993.
Article
CAS
PubMed
Google Scholar
Pepys MB, Baltz ML: Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983, 34: 141-212.
Article
CAS
PubMed
Google Scholar
Benson MD, Cohen AS: Serum amyloid A protein in amyloidosis, rheumatic, and neoplastic diseases. Arthritis Rheum. 1979, 22: 36-42. 10.1002/art.1780220106.
Article
CAS
PubMed
Google Scholar
Malle E, De Beer FC: Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996, 26: 427-435. 10.1046/j.1365-2362.1996.159291.x.
Article
CAS
PubMed
Google Scholar
Clifton PM, Mackinnon AM, Barter PJ: Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985, 26: 1389-1398.
CAS
PubMed
Google Scholar
Kumon Y, Suehiro T, Ikeda Y, Yoshida K, Hashimoto K, Ohno F: Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease. Clin Biochem. 1993, 26: 505-511. 10.1016/0009-9120(93)80016-N.
Article
CAS
PubMed
Google Scholar
Bergmann KC, Crisci CD, Oehling A: The use and limitations of laser nephelometry. Allergol Immunopathol (Madr). 1981, 9: 55-62.
CAS
Google Scholar
Adebajo AO, Cawston TE, Hazleman BL: Routine quantitation of rheumatoid factors: ELISA or nephelometry?. Scand J Rheumatol. 1992, 21: 302-304. 10.3109/03009749209099246.
Article
CAS
PubMed
Google Scholar
Ginel PJ, Margarito JM, Lucena R, Molleda JM: Concentrations of plasma immunoglobulins in the dog as determined by laser nephelometry. Comparison with radial immunodiffusion and enzyme-linked immunosorbent assay. Eur J Clin Chem Clin Biochem. 1997, 35: 223-228.
CAS
PubMed
Google Scholar
Keir G, Barrio S, Thompson EJ: Discrepancies between qualitative and quantitative analysis of cerebrospinal fluid IgG: densitometric comparison of nephelometry-silver versus immuno-enzymes. Ann Clin Biochem. 2008, 45 (Pt 4): 404-408.
Article
CAS
PubMed
Google Scholar
Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM: Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006, 61: 17-22.
Article
CAS
PubMed
Google Scholar
Sin DD, Lacy P, York E, Man SF: Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 170: 760-765. 10.1164/rccm.200404-543OC.
Article
PubMed
Google Scholar
Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R, ABC (Advair Biomarkers in COPD) Investigators: The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 177: 1207-1214. 10.1164/rccm.200709-1356OC.
Article
CAS
PubMed
Google Scholar